Related Experiment Videos
Dermatomyositis in the pediatric patient
Insights
Corticosteroid treatment combined with physical therapy offers a good prognosis for children with dermatomyositis, leading to minimal functional disability. This approach has proven effective in managing the inflammatory condition.
Area of Science:
- Pediatric Rheumatology
- Dermatology
- Neuromuscular Disorders
Background:
- Dermatomyositis is a rare autoimmune disease affecting children.
- It presents with characteristic muscle weakness and skin rash.
- Long-term outcomes and treatment efficacy require further investigation.
Purpose of the Study:
- To evaluate the long-term efficacy of corticosteroid treatment in pediatric dermatomyositis.
- To assess the functional disability and prognosis in a cohort of children with dermatomyositis.
- To analyze the diagnostic value of clinical and laboratory findings.
Main Methods:
- Retrospective analysis of 41 children diagnosed with dermatomyositis.
- Treatment included corticosteroids and individualized physical therapy.
- Follow-up over a 15-year period.
- Assessment of clinical symptoms, serum muscle enzymes, electromyography, and muscle biopsy.
Main Results:
- All patients experienced progressive proximal muscle weakness; 60% reported muscle pain.
- Classic skin rash present in 33 children at diagnosis.
- Serum muscle enzymes, EMG, and biopsy confirmed acute myositis.
- Good prognosis with minimal functional disability observed.
- Three deaths recorded, one definitively linked to dermatomyositis.
Conclusions:
- Adrenal corticosteroid therapy, alongside physical therapy and consistent follow-up, is effective for pediatric dermatomyositis.
- The disease course indicates a favorable prognosis for both survival and functional outcomes.
- Early diagnosis and comprehensive management are crucial for improving patient outcomes.
Abstract:
Forty-one children with dermatomyositis who were treated with corticosteroids and who have been followed over a period of 15 years have been presented. Progressive proximal muscle weakness was seen in all and 60% had muscle pain. The skin rash considered classic for dermatomyositis was seen in 33 children at the time of diagnosis. Elevation of serum muscle enzymes, electromyographic abnormalities, and muscle biopsy evidence of acute myositis were of confirmatory diagnostic value. The course of the disease in this study group has reconfirmed the efficacy of adrenal corticosteroid treatment in conjunction with an individualized physical therapy program and consistent followup. Prognosis for life and minimal functional disability has been good. There have been 3 deaths recorded in this series, only one of which was certain in its relationship to dermatomyositis.